Connect with us

Business

Royalty Pharma expects modest return despite pelacarsen trial failure

Published

on

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Definium Therapeutics, Inc. (DFTX) Discusses Phase III Clinical Progress and Study Outcomes for Lead Program in Mood Disorders Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript